Track 16: Diabetes Gene Therapy

New approaches to the treatment and cure of type 1 diabetes may be developed as a result of recent advances in molecular and cell biology. In instance, the restoration of insulin secretion through gene or cell-replacement treatment can currently be predicted. Over 180 million individuals worldwide are affected with diabetes mellitus, which is on the rise. The majority of cases of diabetes are type 2, and by 2030, the incidence is anticipated to have more than quadrupled due to the ageing population expansion and sharp rise in obesity prevalence.


    Related Conference of Track 16: Diabetes Gene Therapy

    December 09-10, 2024

    17th World Congress on Stem Cell Research

    Dubai, UAE
    December 12-13, 2024

    17th International Conference on Human Genomics and Genomic Medicine

    Dubai, UAE
    December 12-13, 2024

    8th Annual Congress on Soil, Plant and Water Sciences

    Dubai, UAE
    February 24-25, 2025

    19th International Conference on Regenerative Repair and Medicine

    Madrid, Spain
    April 03-04, 2025

    15th International Conference on Human Genetics and Genetic Diseases

    Madrid, Spain
    April 03-04, 2025

    18th International Conference on Genomics & Pharmacogenomics

    Madrid, Spain
    April 14-15, 2025

    8th Annual Conference on Stem Cell and Regenerative Medicine

    Budapest, Hungary
    April 29-30, 2025

    3rd International Conference on Cell Science and Molecular Biology

    Barcelona, Spain
    May 19-20, 2025

    8th Global Conference on Cell and Gene Therapy

    Singapore City, Singapore
    June 12-13, 2025

    13th World Congress on Human Genetics and Genetic Diseases

    London, UK
    June 16-17, 2025

    21st Global Summit on Stem Cell & Regenerative Medicine

    Frankfurt, Germany

    Track 16: Diabetes Gene Therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in